Display options
Cite
Pasalic D, Hegerova LT, Gonsalves WI, et al. An insidious cardiac sarcoma presenting with progressive neurologic dysfunction. Rare Tumors. 2013;5(4):e56doi: 10.4081/rt.2013.e56.
Pasalic, D., Hegerova, L. T., Gonsalves, W. I., & Robinson, S. (2013). An insidious cardiac sarcoma presenting with progressive neurologic dysfunction. Rare tumors, 5(4), e56. https://doi.org/10.4081/rt.2013.e56
Pasalic, Dario, et al. "An insidious cardiac sarcoma presenting with progressive neurologic dysfunction." Rare tumors vol. 5,4 (2013): e56. doi: https://doi.org/10.4081/rt.2013.e56
Pasalic D, Hegerova LT, Gonsalves WI, Robinson S. An insidious cardiac sarcoma presenting with progressive neurologic dysfunction. Rare Tumors. 2013 Oct 18;5(4):e56. doi: 10.4081/rt.2013.e56. eCollection 2013. PMID: 24416490; PMCID: PMC3882928.
Copy Download .nbib Format: NLM
Share it on

Rare Tumors. 2013 Oct 18;5(4):e56. doi: 10.4081/rt.2013.e56. eCollection 2013.

An insidious cardiac sarcoma presenting with progressive neurologic dysfunction.

Rare tumors

Dario Pasalic, Livia T Hegerova, Wilson I Gonsalves, Steven Robinson

Affiliations

  1. Mayo Medical School, Mayo Clinic , Rochester, MN, USA.
  2. Department of General Internal Medicine, Mayo Clinic , Rochester, MN, USA.
  3. Division of Medical Oncology, Mayo Clinic , Rochester, MN, USA.

PMID: 24416490 PMCID: PMC3882928 DOI: 10.4081/rt.2013.e56

Abstract

Central nervous system metastases as the presentation of primary cardiac sarcoma are a very rare entity, with only a few previously reported cases. Sarcomas specifically make up 10 to 20% of all primary cardiac tumors. Patients with primary cardiac tumors typically present with cardiac symptomatology that may include arrhythmias, obstruction to blood flow and valve function, or symptoms of heart failure. We report a unique case of a patient with a primary cardiac sarcoma who presented with progressive neurologic dysfunction secondary to brain metastases without any preceding cardiac symptoms. We describe our novel management of these unique cases and discuss the current medical and surgical approaches to treating neurologic metastases from cardiac sarcoma.

Keywords: cardiac sarcoma; neurologic dysfunction; sarcomas

References

  1. AJR Am J Roentgenol. 1989 Mar;152(3):469-73 - PubMed
  2. J Thorac Cardiovasc Surg. 2009 Jun;137(6):1454-60 - PubMed
  3. Arch Pathol Lab Med. 1999 Sep;123(9):782-8 - PubMed
  4. Hum Pathol. 2008 Sep;39(9):1385-95 - PubMed
  5. Ann Thorac Surg. 2010 Jul;90(1):176-81 - PubMed
  6. Thorac Cardiovasc Surg. 1990 Aug;38 Suppl 2:183-91 - PubMed
  7. J Thorac Cardiovasc Surg. 1996 Oct;112(4):943-53 - PubMed
  8. Cancer. 1986 Feb 15;57(4):852-9 - PubMed
  9. Neurosurgery. 1990 Apr;26(4):692-5 - PubMed
  10. Tex Heart Inst J. 2000;27(2):206-8 - PubMed
  11. Eur J Cardiothorac Surg. 2006 Jun;29(6):925-32 - PubMed
  12. Cancer. 2008 Jun;112(11):2440-6 - PubMed
  13. Cancer. 1993 Mar 1;71(5):1761-73 - PubMed
  14. Heart. 2001 Feb;85(2):218-22 - PubMed

Publication Types